Aminoglycosides Pharmacology Nursing Antibiotics: Mechanism of Action, Mnemonic, Anti-Infectives

RegisteredNurseRN
7 Nov 202211:25

Summary

TLDRThis video covers aminoglycosides, a group of antibiotics primarily targeting gram-negative bacteria. They have a bactericidal effect, making them effective for infections like septicemia, UTIs, and pneumonia. Aminoglycosides inhibit protein synthesis by binding to the 30S ribosomal subunit. They're often used with other antibiotics, like penicillin, for a synergistic effect. The video discusses key drugs in this class, how they're administered, and the importance of monitoring for nephrotoxicity, ototoxicity, and neuromuscular issues, emphasizing the need for careful patient monitoring to avoid adverse effects.

Takeaways

  • 💊 Aminoglycosides are antibiotics primarily targeting gram-negative bacteria, with bactericidal effects that kill the bacteria rather than just inhibiting its growth.
  • 🦠 These antibiotics are effective against bacteria like E. coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Serratia marcescens, but have limited effectiveness against gram-positive bacteria.
  • 🧬 Aminoglycosides work by inhibiting protein synthesis in bacterial cells by targeting the 30S ribosomal subunit, leading to faulty protein production and bacterial death.
  • 💉 Aminoglycosides are usually administered via the IM or IV route, as they are poorly absorbed through the gut, though certain exceptions exist (e.g., neomycin for gut infections).
  • 🧪 Peak and trough levels should be closely monitored due to the narrow therapeutic index, ensuring the drug is effective while avoiding toxicity.
  • 🚨 Nephrotoxicity (kidney damage) and ototoxicity (hearing damage) are major risks of aminoglycosides, requiring careful monitoring of renal function and hearing.
  • 🔬 In some cases, aminoglycosides are combined with other antibiotics like penicillin for a synergistic effect, improving their ability to penetrate bacterial cells.
  • 👂 Ototoxicity, or damage to the ears, is usually irreversible and may present as tinnitus, hearing loss, or dizziness, particularly in patients also taking loop diuretics.
  • 🫁 Neuromuscular blockade, leading to muscle weakness or respiratory failure, is another rare but serious side effect, especially in patients with neuromuscular conditions.
  • 🧴 The mnemonic 'GNATS' helps remember the main aminoglycosides: Gentamicin, Neomycin, Amikacin, Tobramycin, and Streptomycin.

Q & A

  • What types of bacteria do aminoglycosides primarily target?

    -Aminoglycosides primarily target gram-negative microorganisms such as E. coli, Klebsiella pneumonia, Pseudomonas aeruginosa, Serratia marcescens, and Enterobacter. They are less effective against gram-positive bacteria but can target some, like Staphylococcus aureus.

  • How do aminoglycosides kill bacteria?

    -Aminoglycosides work by inhibiting protein synthesis in bacteria. They bind to the 30S subunit of the bacterial ribosome, disrupting the genetic code's reading, leading to the production of faulty proteins, which ultimately causes bacterial death.

  • Why are aminoglycosides often used in combination with other antibiotics?

    -Aminoglycosides are used with other antibiotics, like Penicillin, for a synergistic effect. Penicillin helps aminoglycosides penetrate bacterial cell walls more effectively, enhancing their ability to kill bacteria.

  • What is the mnemonic to remember common aminoglycoside medications?

    -The mnemonic to remember aminoglycosides is 'GNATS': G for Gentamicin, N for Neomycin, A for Amikacin, T for Tobramycin, and S for Streptomycin.

  • How are aminoglycosides typically administered?

    -Aminoglycosides are usually administered via intramuscular (IM) or intravenous (IV) routes because they are not well-absorbed through the gut. Exceptions include Tobramycin for inhalation in cystic fibrosis patients and Neomycin for oral use in specific conditions like hepatic encephalopathy.

  • What conditions can aminoglycosides effectively treat?

    -Aminoglycosides are used to treat septicemia, severe urinary tract infections, infections of the eyes, ears, bones, abdomen, pelvis, endocarditis, and hospital-acquired pneumonia. They can also target mycobacterial infections such as tuberculosis.

  • Why is monitoring peak and trough levels important when administering aminoglycosides?

    -Monitoring peak and trough levels ensures the medication is at a therapeutic level to effectively treat the infection while avoiding toxicity. Peak levels are monitored for effectiveness, and trough levels are monitored to prevent toxic accumulation in the body.

  • What are the major toxic effects of aminoglycosides?

    -Aminoglycosides can cause nephrotoxicity (kidney damage) and ototoxicity (hearing damage). Nephrotoxicity is often reversible, but ototoxicity, affecting hearing and balance, is usually permanent.

  • How can aminoglycosides lead to neuromuscular blockade?

    -Aminoglycosides can cause neuromuscular blockade, leading to muscle weakness and respiratory failure, especially in patients with neuromuscular disorders or those who have received neuromuscular blocking medications during anesthesia.

  • What signs should nurses monitor to ensure aminoglycosides are effectively treating an infection?

    -Nurses should monitor for signs like the resolution of fever, normal blood pressure and heart rate, and normal white blood cell count (5,000-10,000 cells/mcL). These indicators suggest that the infection is being effectively treated.

Outlines

00:00

💉 Overview of Aminoglycosides and Their Bactericidal Effect

Aminoglycosides are a class of antibiotics that target gram-negative bacteria by killing them rather than merely inhibiting growth (bactericidal effect). They are highly effective against organisms like E. coli, Klebsiella, Pseudomonas, and more. Though mainly effective on gram-negative bacteria, they can also target some gram-positive bacteria and mycobacteria. Aminoglycosides are often used in combination with other antibiotics like penicillin to enhance their effect (synergistic effect). A mnemonic 'GNATS' (Gentamicin, Neomycin, Amikacin, Tobramycin, Streptomycin) helps remember the common drugs in this group.

05:02

🔬 Mechanism of Action: Targeting the Ribosome

Aminoglycosides kill bacteria by inhibiting protein synthesis, a vital process for bacterial survival. They specifically bind to the 30S subunit of the ribosome, disrupting the reading of genetic code, leading to the production of faulty proteins. This interference with protein production results in the death of the bacteria. The ribosome consists of two subunits, 50S and 30S, and aminoglycosides particularly affect the 'A' site of the 30S subunit, preventing proper protein assembly.

10:02

🏥 Nursing Role: Monitoring and Toxicity Management

When administering aminoglycosides, nurses should ensure that patients are not allergic, check cultures, and monitor peak and trough levels to avoid toxicity. Peak levels should be measured 1 hour after IM administration or 30 minutes after IV infusion. Trough levels are measured just before the next dose. Nurses should assess whether the treatment is effective (e.g., reduced fever, normal blood pressure, and white blood cell count). It's crucial to monitor for nephrotoxicity (kidney damage) by checking urine output and renal function labs and for ototoxicity (ear damage), especially when patients take other ototoxic drugs like loop diuretics.

👂 Ototoxicity, Nephrotoxicity, and Neuromuscular Risks

Aminoglycosides can cause two primary toxic effects: nephrotoxicity (kidney damage) and ototoxicity (hearing loss or balance issues). Nephrotoxicity may be reversible, so nurses should monitor urine output and renal function tests like BUN and creatinine. Ototoxicity, affecting the cochlear and vestibular systems, is often irreversible, with symptoms like ringing in the ears or dizziness. Patients at higher risk include those taking ototoxic drugs. Additionally, aminoglycosides may cause neuromuscular blockade, especially in patients with preexisting neuromuscular conditions, leading to muscle weakness and respiratory failure.

Mindmap

Keywords

💡Aminoglycosides

Aminoglycosides are a group of antibiotics that primarily target gram-negative bacteria. They have a bactericidal effect, meaning they kill the bacteria rather than just inhibiting its growth. In the video, aminoglycosides are described as effective against serious infections like septicemia, pneumonia, and UTIs, especially when used with other antibiotics for a synergistic effect.

💡Gram-negative bacteria

Gram-negative bacteria are a type of bacteria that have a thinner cell wall but a complex outer membrane, making them more resistant to some antibiotics. In the video, aminoglycosides are highlighted as particularly effective in targeting gram-negative bacteria such as E. coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.

💡Synergistic effect

The synergistic effect refers to the enhanced effectiveness of two or more medications when used together. In the context of the video, combining aminoglycosides with antibiotics like penicillin allows the aminoglycoside to penetrate the bacterial cell wall more effectively, increasing its ability to kill bacteria.

💡Bactericidal

Bactericidal refers to an antibiotic's ability to kill bacteria, as opposed to simply inhibiting its growth (bacteriostatic). Aminoglycosides are described as having a bactericidal effect, directly killing bacteria by inhibiting protein synthesis in bacterial cells, which is critical for their survival.

💡Ribosome

Ribosomes are cellular structures responsible for protein synthesis. In the video, aminoglycosides are explained as working by binding to the 30S subunit of bacterial ribosomes, specifically the A-site, disrupting protein production and leading to the bacteria's death. This inhibition of protein synthesis is the primary mechanism by which aminoglycosides exert their bactericidal effect.

💡Nephrotoxicity

Nephrotoxicity refers to the potential of a drug to cause damage to the kidneys. Aminoglycosides carry a risk of nephrotoxicity, especially when used at high doses or for prolonged periods. The video stresses the importance of monitoring kidney function (such as urine output and creatinine levels) to avoid kidney damage in patients receiving these antibiotics.

💡Ototoxicity

Ototoxicity is a toxic effect on the ear, particularly the hearing structures, which can lead to hearing loss or dizziness. The video highlights that aminoglycosides can cause irreversible ototoxicity, making it important for patients to monitor for symptoms such as ringing in the ears (tinnitus) or dizziness while on the medication.

💡Peak and trough levels

Peak and trough levels refer to the highest and lowest concentrations of a drug in a patient's blood. Monitoring these levels is crucial when administering aminoglycosides, as the video explains. The peak ensures the drug reaches an effective concentration to kill bacteria, while the trough helps prevent toxic side effects by ensuring levels don't get too high.

💡Protein synthesis

Protein synthesis is the process by which cells build proteins, which are vital for cellular functions and survival. In the video, aminoglycosides are said to work by disrupting bacterial protein synthesis. By binding to the bacterial ribosome, they prevent the formation of proper proteins, ultimately leading to the bacteria's death.

💡Mycobacterium tuberculosis

Mycobacterium tuberculosis is the bacterium responsible for tuberculosis (TB). The video mentions that aminoglycosides can target mycobacteria like M. tuberculosis, making these antibiotics useful in treating TB infections, especially in cases resistant to other treatments.

Highlights

Aminoglycosides are a group of antibiotics primarily targeting gram-negative bacteria.

These antibiotics are bactericidal, meaning they kill bacteria rather than just inhibiting their growth.

Aminoglycosides target bacteria like E. coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Serratia marcescens, and Enterobacter.

They are used to treat severe infections like septicemia, urinary tract infections, and hospital-acquired pneumonia.

Aminoglycosides are often combined with other antibiotics like Penicillin for a synergistic effect.

The mnemonic 'GNATS' helps to remember aminoglycosides: Gentamicin, Neomycin, Amikacin, Tobramycin, and Streptomycin.

These antibiotics work by inhibiting protein synthesis within bacterial cells, specifically targeting the 30S ribosomal subunit.

They bind to the A-site of the 30S subunit, causing the bacteria to produce faulty proteins, leading to bacterial death.

Aminoglycosides are typically administered via injection (IM or IV) as they are poorly absorbed through the gut.

Special cases like cystic fibrosis can involve inhalation administration of Tobramycin or oral use of Neomycin for gut bacteria.

The peak and trough levels of aminoglycosides must be closely monitored to avoid toxicity, given their narrow therapeutic index.

Nephrotoxicity (kidney damage) and ototoxicity (hearing damage) are two major risks associated with aminoglycosides.

Nephrotoxicity can potentially be reversed, but ototoxicity is often irreversible.

Patients at higher risk of ototoxicity may be taking other medications like Loop Diuretics or have pre-existing conditions.

In rare cases, aminoglycosides can cause neuromuscular blockade, leading to muscle weakness and respiratory failure.

Transcripts

play00:00

hey everyone it's Sarah with registered

play00:01

nurse rn.com and in this video I'm going

play00:04

to be covering Amino glycosides so let's

play00:07

get started aminoglycosides are a

play00:09

particular group of antibiotics that

play00:11

Target mainly gram-negative

play00:13

microorganisms therefore they're really

play00:16

gram-negative Killers because they have

play00:18

this bacterial subtle effect on the

play00:20

bacteria where they go in and just kill

play00:22

it rather than just inhibiting its

play00:25

growth which would be known as having a

play00:27

bacteriostatic effect now as I cover the

play00:29

different types of antibiotics in this

play00:31

series you're going to see that some

play00:33

antibiotics are really good at killing

play00:35

bacteria whereas other types just really

play00:38

inhibit their growth so what

play00:40

gram-negative bacteria do

play00:42

aminoglycosides Target well they target

play00:45

E coli klebsiella pneumonia a

play00:48

pseudomonas ergonosa serratia marcessins

play00:52

and interobacter now they're not really

play00:54

helpful with targeting grandpas and

play00:57

microorganisms but they can kill a few

play00:59

such as staphylococcus aureus and then

play01:02

enterococcus furthermore aminoglycosides

play01:06

can Target mycobacteria infections such

play01:08

as mycobacterium tuberculosis so because

play01:12

of all these microorganisms that

play01:13

aminoglycosides can Target they're

play01:15

really good at treating certain cases of

play01:17

septicemia where we have infection in

play01:19

the blood severe cases of urinary tract

play01:22

infection and then infections that

play01:24

affect certain parts of the body such as

play01:26

the eyes the ears the bone the abdomen

play01:29

the pelvic areas and they can treat

play01:31

cases of endocarditis where you have

play01:33

infection in the heart specifically on

play01:36

those heart valves and then severe cases

play01:38

of pneumonia that are usually acquired

play01:40

from the hospital setting because those

play01:42

strains tend to be very severe now in

play01:45

practice you may see that

play01:46

aminoglycosides are used in combination

play01:49

with other types of antibiotics and the

play01:51

reason for this is because whenever you

play01:53

throw an aminoglycoside on let's say

play01:56

with Penicillin it all of a sudden has a

play01:58

synergistic effect which means it allows

play02:01

that aminoglycoside to work in ways

play02:03

where it normally wouldn't be able to

play02:05

work if it wasn't on board with this

play02:07

other type of medication so let's say we

play02:09

have Penicillin and aminoglycoside on

play02:11

well aminoglycoside without penicillin

play02:14

normally wouldn't be able to get inside

play02:16

that cell wall and kill it but because

play02:18

we have Penicillin on board we have the

play02:19

synergistic effect and aminoglycoside is

play02:22

able to get in and Target that bacteria

play02:25

so how do we remember the medications

play02:27

that are included with the

play02:29

aminoglycosides well let's remember the

play02:31

word Nats g-n-a-t-s so the GN part is

play02:36

going to help you remember that

play02:37

aminoglycosides mainly Target

play02:40

gram-negative

play02:41

microorganisms so the G is for

play02:45

Gentamicin n is for neomycin

play02:48

A is for Emma Cason T is for Tobramycin

play02:53

and then the last one s is for

play02:55

streptomycin now as you can see these

play02:57

medications in in mycin whether

play03:00

m-i-c-i-n or m-y-c-i-n but don't let

play03:03

that tip you off that it's an

play03:05

aminoglycoside because some other groups

play03:08

of antibiotics such as the microlides

play03:10

they end in nycin some of them do like

play03:14

erythromycin so that might throw you off

play03:16

and get you a little confused so just

play03:18

try to remember the names with this

play03:20

mnemonic and just know that

play03:22

unfortunately it doesn't follow that

play03:23

rule that sometimes we can use with

play03:25

those names now how are aminoglycosides

play03:28

administered well this particular group

play03:30

of medications doesn't like to be

play03:33

absorbed through the gut so we don't

play03:35

like to give them orally but rather we

play03:37

like to give them via the parental route

play03:39

so the im or IV route now there are some

play03:43

exceptions to this depending on what's

play03:45

going on with the patient for instance

play03:47

to cobramycin can be given via

play03:50

inhalation to patients who have cystic

play03:53

fibrosis and they have a lung infection

play03:55

or we can give neomycin via the oral

play03:59

route if we're trying to Target certain

play04:01

bacteria in the gut for instance if the

play04:04

patient has hepatic encephalopathy we

play04:06

can give them neomycin to help bring

play04:09

down that ammonia level or let's say the

play04:11

patient's having bowel surgery we can

play04:14

give them this to help prep that bowel

play04:16

before they actually have surgery so now

play04:18

let's talk about how aminoglycosides

play04:20

work and how they actually kill that

play04:22

bacteria well depending on the

play04:25

antibiotic group you're talking about

play04:26

they will Target certain parts of that

play04:28

bacterial cell some will inhibit the

play04:31

cell wall synthesis of that bacteria

play04:33

While others will inhibit nucleic acid

play04:35

synthesis and then some will inhibit

play04:37

protein synthesis within that bacterial

play04:39

cell and that is what aminoglycosides do

play04:42

they inhibit protein synthesis inside

play04:44

that bacterial cell so we don't get the

play04:46

creation of proteins now now proteins

play04:49

are really important for that bacterial

play04:51

survival it's really the backbone of its

play04:54

ability to thrive and survive so if we

play04:57

can stop that process of that bacteria

play04:59

that's inhabited our body we can kill it

play05:01

and get rid of it and that's what

play05:02

aminoglycosides do so what makes the

play05:06

proteins in that bacteria cell it is the

play05:08

ribosome so remember ribosome it's it's

play05:11

what we're targeting so the ribosome is

play05:13

a really cool structure it is made up of

play05:16

two subunits you have a large subunit

play05:19

known as 50s and then you have a smaller

play05:21

one known as 30s and these two subunits

play05:25

work together to their whole goal is to

play05:28

stack amino acids together and make a

play05:31

beautiful polypeptide chain hence our

play05:34

protein

play05:35

so aminoglycosides say I need to stop

play05:39

this process so I'm going to affect one

play05:42

of these subunits so we can't have this

play05:44

happen making these polypeptide chains

play05:47

so what it does is aminoglycosides binds

play05:50

to the 30s on the ribosome so it binds

play05:54

to the subunit particularly it's a site

play05:57

so remember aminoglycoside starts with a

play06:00

it targets the a site of 30s and

play06:03

whenever it does this it causes its

play06:06

genetic code to not be read properly so

play06:09

we don't have good instructions

play06:10

happening here so we're not going to

play06:13

really make great healthy proteins

play06:15

instead we're going to make junky

play06:16

proteins and junkie proteins lead to the

play06:19

death of that bacteria can't function if

play06:22

it doesn't have healthy ones so there we

play06:24

get that bacterial subtle effect and

play06:26

that is how in the end they kill the

play06:28

bacteria now let's talk about our role

play06:31

as the nurse whenever we're

play06:32

administering aminoglycosides so before

play06:35

administer during these medications you

play06:37

want to confirm that your patient is not

play06:38

allergic to them and that you've

play06:41

obtained any necessary cultures that

play06:43

have been ordered by The Physician and

play06:45

that you are monitoring the peak and

play06:47

trough levels why your patient is taking

play06:49

this group of antibiotics and the reason

play06:51

for this is because these medications

play06:53

are very powerful so we want to make

play06:55

sure our patient's not becoming too

play06:56

toxic on them because it has a very

play06:59

narrow therapeutic index but we want to

play07:01

make sure that the medications being

play07:03

effective and that they have enough of

play07:05

the medication in their system to really

play07:06

Target that bacteria and kill it so

play07:09

first let's talk about Peak so the peak

play07:11

is the highest concentration of the

play07:13

medication in the blood so remember this

play07:16

medication can be given I am or IV so if

play07:19

your patient's getting an IM you would

play07:21

want to do a blood draw for the peak one

play07:24

hour after the injection but let's say

play07:26

your patient is getting it IV it's

play07:29

typically a 30 minute infusion so you

play07:32

would want to do a blood draw about 30

play07:34

minutes after the infusion has been

play07:37

completed and then the trough is the

play07:39

lowest concentration of the medication

play07:41

in the patient's system and we're really

play07:43

interested in this level because it

play07:44

helps us monitor for toxicity so if your

play07:47

patient's getting an IM or IV you would

play07:50

just collect it you do a blood draw

play07:52

right before the next dose and then

play07:54

another thing you want to be monitoring

play07:55

for is that this medication is working

play07:57

like it should so is the medication

play08:00

treating this infection what are some

play08:02

signs that tells you it's doing that

play08:04

well the patient doesn't have a fever

play08:06

anymore those fevers are dropping or

play08:08

they just don't have one anymore they're

play08:09

normal

play08:10

they don't show signs and symptoms of

play08:12

sepsis so their blood pressure is within

play08:14

normal range it's not hypotensive and

play08:16

their heart rates within normal range is

play08:17

not tachycardic and their white blood

play08:20

count is in normal range like five

play08:22

thousand to ten thousand anything

play08:24

greater than that tells us oh the white

play08:26

blood cells are on board we've got a

play08:28

massive infection because that's what

play08:30

white blood cells do they target

play08:31

bacteria so if they're elevated that's

play08:34

not a good thing now let's talk about

play08:35

the toxic effects that aminoglycosides

play08:38

can have in your patient that you want

play08:40

to monitor for so two terms I want you

play08:42

to remember nephrotoxic and ototoxic so

play08:45

in an O So in aminoglycosides remember

play08:48

the n and the O for nephrotoxic and

play08:51

ototoxic so nephro toxic in medical

play08:55

terminology remember nephro meant

play08:57

kidneys so we're talking about the

play08:58

kidneys the kidneys can really be

play09:00

affected and if they're affected it

play09:02

could be reversed so we can reverse the

play09:04

nephrotoxicity and what happens what

play09:07

increases the patient's risk of having

play09:09

this is that they've been using

play09:10

aminoglycosides for too long or they're

play09:12

on a really high dose so as a nurse when

play09:15

you want to be looking out for is you

play09:16

want to be looking at the patient's

play09:18

urinary output make sure that they're

play09:20

putting out a normal amount of urine so

play09:22

typically that's 30 ml per hour for an

play09:26

adult and you want to be looking at

play09:28

those labs that tells you about the

play09:29

renal function these will be ordered so

play09:31

you want to look those over like for

play09:33

instance the bun you want to make sure

play09:35

that's within normal limits like 5 to

play09:37

20. and they're creating level anywhere

play09:39

between 0.6 to 1.2 milligrams per

play09:42

deciliter it varies depending on male

play09:44

and female and then you want to look at

play09:46

their GFR that is a glomerular

play09:48

filtration rate and this is the rate

play09:51

that our glomerulus filters waste ions

play09:54

and water so anything less than 90 ml

play09:57

per minute is concerning so we want to

play09:59

make sure that it doesn't get there now

play10:01

the next type of toxic your patient can

play10:03

experience is ototoxicity and Odo

play10:06

remember means ears and we're

play10:08

specifically talking about those hearing

play10:09

structures in the ear now if your

play10:11

patient experiences this unfortunately

play10:13

it's not likely going to be reversed

play10:15

like over here with the kidneys and what

play10:18

increases your patient's risk of

play10:19

developing this is if they're taking

play10:20

other medications that can really cause

play10:23

this to happen for instance if they're

play10:24

taking Loop Diuretics like furosemide it

play10:27

increases the risk of them developing

play10:29

hearing problems so because this

play10:31

medication can damage the vestibular and

play10:34

cochlear parts of the ears you want to

play10:36

tell your patient to Monitor and to

play10:38

report any type of ringing in the ear

play10:40

hearing loss or feeling dizzy because

play10:42

this could be a sign that this

play10:44

medication is messing with the ears and

play10:46

then lastly this medication can cause a

play10:49

neuromuscular blockade so this can be

play10:51

experienced through muscle weakness and

play10:53

respiratory failure and it tends to

play10:55

happen in patients who've received

play10:57

neuromuscular blocking medications like

play10:59

during anesthesia or who have

play11:02

neuromuscular disorders like myasthenia

play11:04

gravis so in these patients you want to

play11:07

make sure that you're on high alert for

play11:09

these potential problems like muscle

play11:11

weakness and respiratory failure that

play11:13

could develop while taking this

play11:14

medication okay so that wraps up this

play11:16

review over aminoglycosides and if you'd

play11:19

like to watch more review lectures over

play11:20

antibiotics in this series you can

play11:22

access the link in the YouTube

play11:23

description below

Rate This

5.0 / 5 (0 votes)

Etiquetas Relacionadas
AminoglycosidesAntibioticsGram-negative bacteriaNursing tipsInfection controlSepsis treatmentToxicity risksProtein synthesisHealthcare educationPharmacology
¿Necesitas un resumen en inglés?